This article is more than 5 years old. Information may no longer be current.

First patient implanted with STARflo glaucoma drainage device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

iStar Medical announced that the first patient from its multicenter European clinical study has been implanted successfully with the STARflo glaucoma drainage device, according to a company press release.

STARflo is a nondegradable, precision-pore implant made from STAR biomaterial designed to operate as a bleb-free, microporous drainage system to reduce IOP by augmenting the natural uveoscleral outflow of the eye. The study will evaluate the safety and effectiveness of the STARflo device in patients with open-angle glaucoma, according to the release.

“The STARflo device provides a unique drainage mechanism for patients presenting with advanced or refractory glaucoma and fills an unmet clinical need for patients at high risk of failure following traditional filtering surgery,” Christophe Baudouin, MD, PhD, the surgeon who implanted the first STARflo device, said in the release.

STARflo was granted CE mark in 2012 and is currently available in select countries, according to the release.